
Eli Lilly acquires Centessa Pharmaceuticals in $6.3 billion deal for sleep disorder drugs
Varney & Company · FBN · Mar 31, 2026 · 32sSign Up NowAlready a subscriber?
Fox Business reports that Eli Lilly is acquiring Centessa Pharmaceuticals for $6.3 billion, giving Eli Lilly access to experimental drugs designed to treat sleep disorders like narcolepsy. Eli Lilly's stock is up nearly 3%, while Centessa Pharmaceuticals' stock surged by over 44% on the news.